Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PPARA | Q07869 | 5/20 | 0.46 |
| ▸ | PPARG | P37231 | 3/20 | 0.46 |
| ▸ | CNR2 | P34972 | 6/20 | 0.45 |
| ▸ | CNR1 | P21554 | 4/20 | 0.45 |
| ▸ | P2RY10 | O00398 | 4/20 | 0.40 |
| ▸ | CYP2D6 | P10635 | 2/20 | 0.40 |
| ▸ | GPR174 | Q9BXC1 | 3/20 | 0.39 |
| ▸ | GPR34 | Q9UPC5 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10805717 | 1.00 | PPARA (0.46) | PPARAPPARGCNR2CNR1P2RY10 | |
| SCHEMBL10807777 | 0.94 | PPARA (0.46) | PPARAPPARGCNR2CNR1P2RY10 | |
| SCHEMBL10805731 | 0.94 | PPARA (0.46) | PPARAPPARGCNR2CNR1P2RY10 | |
| SCHEMBL10804840 | 0.91 | PPARA (0.47) | PPARAPPARGCNR2CNR1CYP2D6 | |
| SCHEMBL10806823 | 0.91 | PPARA (0.47) | PPARAPPARGCNR2CNR1CYP2D6 | |
| SCHEMBL10810983 | 0.90 | PPARA (0.46) | PPARAPPARGCNR2CNR1P2RY10 | |
| SCHEMBL10809134 | 0.90 | PPARA (0.46) | PPARAPPARGCNR2CNR1P2RY10 | |
| SCHEMBL10812959 | 0.89 | CNR2 (0.43) | CNR2CNR1 | |
| SCHEMBL10806725 | 0.88 | PPARA (0.46) | PPARAPPARGCNR2CNR1CYP2D6 | |
| SCHEMBL10811852 | 0.88 | PPARA (0.46) | PPARAPPARGCNR2CNR1CYP2D6 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-4640913-A | Phosphocholine derivatives having antihypertensive action | AMERICAN CYANAMID COMPANY (US) | 1987-02-03 | — | — | US | disclosed |